✦ LIBER ✦

Pharmacokinetics of sisomicin in patients with normal and impaired renal function; its efficacy in urinary tract infection

✍ Scribed by S. Roth; K. Naber; M. Scheer; G. Gruenwaldt; H. Lange

Publisher: Springer
Year: 1976
Tongue: English
Weight: 943 KB
Volume: 10
Category: Article
ISSN: 0031-6970
DOI: 10.1007/bf00565626

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics and efficacy of sisomic

Pharmacokinetics and efficacy of sisomicin in patients with urinary tract infections

✍ L. Weissbach; J. Gillissen; H. Lode 📂 Article 📅 1979 🏛 Springer-Verlag 🌐 English ⚖ 272 KB

Treatment with sisomicin of complicated

Treatment with sisomicin of complicated urinary tract infections in patients with varying degrees of renal function impairment

✍ A. Mosegaard; P. G. Welling; F. L. S. Tse; P. Madsen 📂 Article 📅 1975 🏛 Springer-Verlag 🌐 English ⚖ 530 KB

Efficacy and pharmacokinetics of tobramy

Efficacy and pharmacokinetics of tobramycin in patients with chronic urinary tract infections and various degrees of renal impairment

✍ S. R. Westenfelder; P. G. Welling; P. O. Madsen 📂 Article 📅 1974 🏛 Springer-Verlag 🌐 English ⚖ 540 KB

Pharmacokinetics of sisomicin in normal

Pharmacokinetics of sisomicin in normal patients and those with depressed renal function

✍ H. Neu; G. Appel; M. Parry; G. Garvey; G. Jacob 📂 Article 📅 1976 🏛 Springer-Verlag 🌐 English ⚖ 274 KB

Sisomicin: Pharmacokinetics and therapy

Sisomicin: Pharmacokinetics and therapy in patients with normal and reduced renal function

✍ K. Naber; S. Roth; H. Lange 📂 Article 📅 1979 🏛 Springer-Verlag 🌐 English ⚖ 139 KB

Pharmacokinetics of nicorandil in patien

Pharmacokinetics of nicorandil in patients with normal and impaired renal function

✍ M. Molinaro; G. Villa; M. B. Regazzi; A. Salvadeo; S. Segagni; R. Rondanelli; E. 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 489 KB

The pharmacokinetics of oral nicorandil 20 mg 12 hourly for 9 doses was evaluated in 21 hospitalized patients with angina pectoris due to coronary heart disease and with normal and impaired renal function. Patients were divided into 3 groups based on creatinine clearance (CLCr): GROUP I (n = 6) grea